journal article·2018-11-05Open access

Nanomedicines as emerging platform for simultaneous delivery of cancer therapeutics: new developments in overcoming drug resistance and optimizing anticancer efficacy

Zahid Hussain, Mahwish Arooj, Arif Malik, Fahad Hussain, Hassan Safdar, Shahzeb Khan, Muhammad Sohail, Manisha Pandey, Hira Choudhury, Hnin Ei Thu

Abstract

Development and formulation of an efficient and safe therapeutic regimen for cancer theranostics are dynamically challenging. The use of mono-therapeutic cancer regimen is generally restricted to optimal clinical applications, on account of drug resistance and cancer heterogeneity. Combinatorial treatments can employ multi-therapeutics for synergistic anticancer efficacy whilst reducing the potency of individual moieties and diminishing the incidence of associated adverse effects. The combo-delivery of nanotherapeutics can optimize anti-tumor efficacy while reversing the incidence of drug resistance, aiming to homogenize pharmacological profile of drugs, enhance circulatory time, permit targeted drug accumulation, achieve multi-target dynamic approach, optimize target-specific drug binding and ensure sustained drug release at the target site. Numerous nanomedicines/nanotherapeutics have been developed by having dynamic physicochemical, pharmaceutical and pharmacological implications. These innovative delivery approaches have displayed specialized treatment effects, alone or in combination with conventional anticancer approaches (photodynamic therapy, radiotherapy and gene therapy), while reversing drug resistance and potential off-target effects. The current review presents a comprehensive overview of nanocarrier aided multi-drug therapies alongside recent advancements, future prospects, and the pivotal requirements for interdisciplinary research.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutics, Faculty of Pharmacy, Universiti Teknologi MARA (UiTM), Selangor, Malaysia;

University College of Medicine and Dentistry (UCMD), The University of Lahore, Lahore, Pakistan;

Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Lahore, Pakistan;

Department of Biochemistry, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan;

Department of Pharmacy, University of Malakand, Lower Dir, KPK, Pakistan;

Department of Pharmacy, COMSATS Institute of Information Technology, Abbottabad, Pakistan;

Department of Pharmaceutical Technology, School of Pharmacy, International Medical University-Bukit Jalil, Kuala Lumpur, Malaysia;

Department of Pharmacology and Dental Therapeutics, Faculty of Dentistry, Lincoln University College, Petaling Jaya, Malaysia,

Funding

Institute of Research Management and Innovation (IRMI), Universiti Teknologi MARA

References (55)

Show source-provided references
1. 10.1038/clpt.2013.17410.1038/clpt.2013.174 ↗
2. 10.1126/scisignal.200526110.1126/scisignal.2005261 ↗
3. 10.1038/nature1262510.1038/nature12625 ↗
4. 10.1073/pnas.131184611110.1073/pnas.1311846111 ↗
5. 10.1016/j.drup.2012.10.00210.1016/j.drup.2012.10.002 ↗
6. 10.1016/j.jconrel.2012.05.05110.1016/j.jconrel.2012.05.051 ↗
7. 10.1038/nrc318010.1038/nrc3180 ↗
8. 10.1158/0008-5472.CAN-12-456110.1158/0008-5472.CAN-12-4561 ↗
9. 10.1021/nn300652p10.1021/nn300652p ↗
10. 10.1002/adma.20110471410.1002/adma.201104714 ↗
11. 10.1038/nbt.228410.1038/nbt.2284 ↗
12. 10.1038/nature1262610.1038/nature12626 ↗
13. 10.1007/s12033-010-9321-210.1007/s12033-010-9321-2 ↗
14. 10.1002/msb.2013489210.1002/msb.20134892 ↗
15. 10.1158/1078-0432.CCR-13-322710.1158/1078-0432.CCR-13-3227 ↗
16. 10.1158/1078-0432.CCR-14-072410.1158/1078-0432.CCR-14-0724 ↗
17. 10.1200/JCO.2010.28.098210.1200/JCO.2010.28.0982 ↗
18. 10.1200/JCO.2011.35.672510.1200/JCO.2011.35.6725 ↗
19. 10.1016/S1470-2045(10)70132-710.1016/S1470-2045(10)70132-7 ↗
20. 10.1016/S1470-2045(14)70379-110.1016/S1470-2045(14)70379-1 ↗
21. 10.1021/nl404360k10.1021/nl404360k ↗
22. 10.1016/j.biomaterials.2013.07.03810.1016/j.biomaterials.2013.07.038 ↗
23. 10.1016/S0168-3659(00)00339-410.1016/S0168-3659(00)00339-4 ↗
24. 10.1021/acsami.5b0401510.1021/acsami.5b04015 ↗
25. 10.1016/j.jconrel.2015.01.02610.1016/j.jconrel.2015.01.026 ↗
26. 10.1021/mp500009r10.1021/mp500009r ↗
27. 10.1016/j.jconrel.2015.08.00210.1016/j.jconrel.2015.08.002 ↗
28. 10.1021/ja508802410.1021/ja5088024 ↗
29. 10.1021/nn507034310.1021/nn5070343 ↗
30. 10.1016/j.jconrel.2015.05.27110.1016/j.jconrel.2015.05.271 ↗
31. 10.1016/j.addr.2009.05.00610.1016/j.addr.2009.05.006 ↗
32. 10.1016/j.nano.2015.03.01510.1016/j.nano.2015.03.015 ↗
33. 10.1016/j.biomaterials.2014.05.00410.1016/j.biomaterials.2014.05.004 ↗
34. 10.1158/1078-0432.CCR-15-086610.1158/1078-0432.CCR-15-0866 ↗
35. 10.1016/j.biomaterials.2013.01.05310.1016/j.biomaterials.2013.01.053 ↗
36. Wu H · Cancer Res · 2003 · 63 · 1515
37. 10.1021/nn304406610.1021/nn3044066 ↗
38. 10.1097/CCO.0b013e3282f31d6f10.1097/CCO.0b013e3282f31d6f ↗
39. 10.1517/17425247.2013.75863110.1517/17425247.2013.758631 ↗
40. 10.1002/adfm.20150200310.1002/adfm.201502003 ↗
41. 10.1016/j.jconrel.2015.04.00710.1016/j.jconrel.2015.04.007 ↗
42. 10.1039/B821763G10.1039/B821763G ↗
43. 10.1002/adma.20100104010.1002/adma.201001040 ↗
44. 10.1016/j.jconrel.2011.10.02810.1016/j.jconrel.2011.10.028 ↗
45. 10.1007/s11095-013-1180-710.1007/s11095-013-1180-7 ↗
46. 10.1039/c2cc33543c10.1039/c2cc33543c ↗
47. 10.1016/j.addr.2013.10.00210.1016/j.addr.2013.10.002 ↗
48. 10.1039/C4RA03993A10.1039/C4RA03993A ↗
49. 10.1016/j.biomaterials.2011.07.07110.1016/j.biomaterials.2011.07.071 ↗
50. 10.1038/nrc107110.1038/nrc1071 ↗
51. 10.1016/j.jphotobiol.2014.07.00510.1016/j.jphotobiol.2014.07.005 ↗
52. 10.1016/j.biomaterials.2008.05.01810.1016/j.biomaterials.2008.05.018 ↗
53. 10.1016/j.biomaterials.2009.03.04810.1016/j.biomaterials.2009.03.048 ↗
54. 10.1039/C4NR03693J10.1039/C4NR03693J ↗
55. 10.1021/nn506949t10.1021/nn506949t ↗